Pharmacies in England to complete next clinical audit with focus on valproate

Date:

Share post:

Community pharmacies in England will have to go through a clinical audit focusing on valproate, following an agreement reached between the PSNC and NHS England and NHS Improvement (NHSE&I).

The audit, a part of NHS contractual requirements, aims to reduce the potential harm caused by taking valproate during pregnancy.

The 2021/22 audit will be based on the Pharmacy Quality Scheme (PQS) audit, allowing contractors to close the cycle by re-auditing their practice.

NHSE&I recently shared the results of the PQS 2019/20 valproate audit.

Around 5.6 per cent of the 12,068 girls or women of childbearing potential who participated in the audit said they were not advised in line with the MHRA Drug Safety Update 2018 relating to the potential impact on an unborn child.

Of the total, 10.6 per cent did not have a copy of the Patient Guide and 11.1 per cent did not have a copy of the Patient Alert Card.

PSNC said that the audit result shows, “there is still more work to be done to ensure women and girls receive the correct information about valproate and the risk of birth defects.”

PSNC director of NHS Services, Alastair Buxton, said: “Pharmacy teams have a vital role to play in ensuring valproate is prescribed and dispensed safely to women and girls.

“Many contractors have told us they want to see the results of previous audits shared and the audit cycle being completed; this audit will achieve that aim, building on the important work that pharmacy teams completed in the 2019/20 PQS and supporting further action to address this important patient safety issue.”

The negotiator will alert contractors once the paperwork for the audit is finalised.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue October 2023

Related articles

England lost more than 1,000 pharmacies in the last eight years, says CCA

Community pharmacies are currently facing a worrying mix of funding, workforce, and workload pressures The Company Chemists’ Association...

NHS care delays led to 112 deaths, harmed 8,000 people in England last year

The number of patients dying due to care delays have risen more than fivefold over the last three...

Whitworth Chemists puts six high-dispensing Blackpool pharmacies up for sale

The family-owned business has decided to sell all 34 pharmacies across the North of England Whitworth Chemists Limited...

Babies born with Wolman disease can now receive a life-saving treatment on the NHS

The new enzyme replacement therapy improves patient’s life expectancy and quality of life in clinical trials   For the first...